Venus Remedies Ltd Surges 27.61% in Five Days: 5 Key Drivers Behind the Rally

1 hour ago
share
Share Via
Venus Remedies Ltd delivered a remarkable 27.61% gain over the week ending 5 June 2026, vastly outperforming the Sensex which declined by 0.78%. The stock consistently hit new 52-week and all-time highs each trading day, driven by strong financial results, technical momentum, and growing institutional interest. Despite a mixed broader market, Venus Remedies demonstrated resilience and bullish sentiment, culminating in a nine-day winning streak and multiple upper circuit hits.

Key Events This Week

1 Jun: New 52-week and all-time high at Rs.1,346.95 with upper circuit hit

2 Jun: Stock surged to Rs.1,414.25, again hitting upper circuit amid strong volume

3 Jun: Continued rally to Rs.1,484.95, marking eighth consecutive gain and upper circuit

4 Jun: New 52-week high of Rs.1,559.15 with upper circuit and strong institutional buying

5 Jun: Week closes at Rs.1,637.10, up 5.00% on the day, extending the winning streak

Week Open
Rs.1,282.85
Week Close
Rs.1,637.10
+27.61%
Week High
Rs.1,637.10
vs Sensex
+28.39%

1 June 2026: Breakout to New Highs with Upper Circuit

Venus Remedies Ltd began the week with a strong 5.00% gain, closing at Rs.1,346.95, a new 52-week and all-time high. The stock hit its upper circuit limit, reflecting intense buying pressure and a scarcity of sellers. Despite a 0.96% decline in the Sensex, Venus Remedies outperformed significantly, supported by robust financials including record quarterly net sales of Rs.259.40 crore and a PBDIT of Rs.63.42 crore. Institutional investors increased their stake by 0.72%, now holding 4% of shares, signalling growing confidence.

2 June 2026: Sustained Momentum and Strong Volume

The rally continued as Venus Remedies surged another 5.00% to Rs.1,414.25, again hitting the upper circuit. The stock outperformed the Sensex, which rose modestly by 0.43%. Trading volumes were robust, with turnover reaching ₹33.27 crore, underscoring strong liquidity despite the micro-cap status. Technical indicators remained bullish, with the stock trading above all key moving averages and positive signals from MACD and Bollinger Bands. The company’s net-debt-free status and strong return ratios further supported investor enthusiasm.

3 June 2026: Eighth Consecutive Gain Amid Market Weakness

Venus Remedies extended its winning streak to eight days, closing at Rs.1,484.95 with a 5.00% gain and another upper circuit hit. This performance contrasted sharply with the Sensex’s 1.23% decline. The stock’s cumulative return over this period reached 43.97%. Institutional delivery volumes surged by 194.64%, indicating strong accumulation. The company’s operating profit growth of 45.72% annually and net profit surge of 126.19% in the latest quarter underpinned the rally. Technical momentum remained strong, with bullish weekly and monthly indicators.

Rising fast and still accelerating! This Small Cap from FMCG sector is riding pure momentum right now. Jump in before the rally reaches its peak!

  • - Accelerating price action
  • - Pure momentum play
  • - Pre-peak entry opportunity

Jump In Before It Peaks →

4 June 2026: New 52-Week High and Upper Circuit Amid Mixed Market

Venus Remedies hit a fresh 52-week and all-time high of Rs.1,559.15, gaining 5.00% and hitting the upper circuit once more. This marked the ninth consecutive day of gains and a cumulative return of 51.17%. The stock outperformed the Pharmaceuticals & Biotechnology sector by 5.24% and the Sensex, which declined by 0.55%. Despite mixed signals from the Relative Strength Index, the overall technical picture remained bullish with strong MACD and Bollinger Bands readings. Institutional investors continued to increase holdings, reflecting confidence in the company’s growth trajectory.

5 June 2026: Week Closes Strong at Rs.1,637.10

Extending the winning streak to ten days, Venus Remedies closed the week at Rs.1,637.10, up 5.00% on the day. The stock’s weekly gain of 27.61% dwarfed the Sensex’s 0.78% decline, highlighting exceptional outperformance. The sustained rally was supported by strong fundamentals, including a net-debt-free balance sheet, record quarterly sales, and robust profitability metrics. Technical indicators continued to signal strength, with the stock trading comfortably above all major moving averages and maintaining positive momentum across multiple timeframes.

Venus Remedies Ltd caught your attention? Explore our comprehensive research report with in-depth analysis of this micro-cap stock – fundamentals, valuations, financials, and technical outlook!

  • - Comprehensive research report
  • - In-depth micro-cap analysis
  • - Valuation assessment included

Explore In-Depth Research →

Date Stock Price Day Change Sensex Day Change
2026-06-01 Rs.1,346.95 +5.00% 35,077.62 -0.96%
2026-06-02 Rs.1,414.25 +5.00% 35,227.64 +0.43%
2026-06-03 Rs.1,484.95 +5.00% 35,107.33 -0.34%
2026-06-04 Rs.1,559.15 +5.00% 35,175.61 +0.19%
2026-06-05 Rs.1,637.10 +5.00% 35,141.95 -0.10%

Key Takeaways

Strong Outperformance: Venus Remedies Ltd’s 27.61% weekly gain vastly outpaced the Sensex’s 0.78% decline, highlighting exceptional relative strength in a mixed market environment.

Consistent New Highs and Upper Circuits: The stock hit new 52-week and all-time highs every trading day, with multiple upper circuit hits signalling intense buying interest and limited supply.

Robust Financials: Record quarterly net sales of Rs.259.40 crore and PBDIT of Rs.63.42 crore, alongside net profit growth of 126.19%, underpin the rally. The company remains net-debt free with strong return ratios (ROCE 19.85%, ROE 15.5%).

Technical Momentum: Trading above all key moving averages with bullish MACD, Bollinger Bands, and other indicators on weekly and monthly charts, the stock’s technical outlook remains positive.

Growing Institutional Interest: Institutional holdings increased by 0.72% to 4%, reflecting confidence in the company’s fundamentals and growth prospects.

Conclusion

Venus Remedies Ltd’s extraordinary weekly performance, marked by a 27.61% gain and a series of new highs, underscores its strong position within the Pharmaceuticals & Biotechnology sector. Supported by robust financial results, positive technical indicators, and increasing institutional participation, the stock has demonstrated resilience amid broader market volatility. The sustained momentum and multiple upper circuit hits reflect strong investor confidence, although the micro-cap status suggests that volatility and liquidity considerations remain relevant. Overall, Venus Remedies Ltd’s rally this week highlights its capacity to deliver market-beating returns and maintain bullish momentum in a challenging environment.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News